MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617048559 A) filed by Excalipoint Biotechnology Shanghai Co. , Limited on April 16, 2026, for Multispecific Antibodies And Uses Thereof.
Inventors include Yang, Liu; Gao, Shan; Cai, Zhijian; Jiang, Wenqing; Cui, Feifei; Zhang, Xiaoli; and Fang, Lei.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: T cell engagers that target both CD3 and 4-1BB are described, in which both targeting moieties have balanced activities to ensure efficacy and safety. For instance, the anti-CD3 moiety can have a T cell activation activity in the range of 0.5 to 10 nM, and the anti-4-1BB moiety can have a 4-1BB sign...